June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Biogen (BIIB) stock forecast for 2026
Updated: May 31, 2025 (05:32)
Sector: HealthcareThe share price of Biogen Inc. (BIIB) now
50/200 Day Moving Average: $125.32 / $156.97
This figure corresponds to the Average Price over the previous 50/200 days. For Biogen stocks, the 50-day moving average is the resistance level today.
For Biogen stocks, the 200-day moving average is the resistance level today.
Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biogen stock price in 2026. How much will one Biogen share be worth in 2026? Is it worth taking profit / loss on BIIB stock now or waiting? What are analysts' forecasts for Biogen stock?
We forecast Biogen stock performance using neural networks based on historical data on BIIB stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Biogen Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Biogen analysts is $171.95. Today 200 Day Moving Average is the resistance level (156.97 $). 50 Day Moving Average is the resistance level (125.32 $).
Historical and forecast chart of Biogen Inc. stock
The chart below shows the historical price of Biogen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BIIB stock price can be found in the table below.
Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.
The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.
Biogen (BIIB) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 108.82 | 102.42 | 113.78 | 9.99 % |
| Mar | 106.99 | 103.01 | 114.82 | 10.29 % |
| Mar | 103.78 | 100.04 | 107.26 | 6.73 % |
| May | 92.32 | 84.23 | 94.76 | 11.11 % |
| May | 86.12 | 78.06 | 93.56 | 16.57 % |
| Jul | 85.29 | 81.30 | 92.56 | 12.16 % |
| Jul | 88.46 | 80.71 | 94.51 | 14.60 % |
| Aug | 88.67 | 82.50 | 95.06 | 13.21 % |
| Oct | 99.00 | 90.09 | 102.80 | 12.37 % |
| Oct | 103.51 | 94.82 | 109.97 | 13.78 % |
| Dec | 100.78 | 94.01 | 103.80 | 9.44 % |
| Dec | 101.14 | 98.23 | 107.45 | 8.58 % |
Biogen information and performance
225 BINNEY STREET, CAMBRIDGE, MA, US
Market capitalization of the Biogen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BIIB shares in the company outstanding by the market price of one share.
EBITDA of Biogen is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Biogen price target for 2026 by month
Target values for the price of one Biogen share for Jan 2026.
In Jan, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 9.985% volatility is expected.
Pessimistic target level: 102.42
Optimistic target level: 113.78
Target values for the price of one Biogen share for Mar 2026.
In Mar, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 10.287% volatility is expected.
Pessimistic target level: 103.01
Optimistic target level: 114.82
Target values for the price of one Biogen share for Mar 2026.
In Mar, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 6.734% volatility is expected.
Pessimistic target level: 100.04
Optimistic target level: 107.26
Target values for the price of one Biogen share for May 2026.
In May, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 11.107% volatility is expected.
Pessimistic target level: 84.23
Optimistic target level: 94.76
Target values for the price of one Biogen share for May 2026.
In May, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 16.568% volatility is expected.
Pessimistic target level: 78.06
Optimistic target level: 93.56
Target values for the price of one Biogen share for Jul 2026.
In Jul, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 12.164% volatility is expected.
Pessimistic target level: 81.30
Optimistic target level: 92.56
Target values for the price of one Biogen share for Jul 2026.
In Jul, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 14.601% volatility is expected.
Pessimistic target level: 80.71
Optimistic target level: 94.51
Target values for the price of one Biogen share for Aug 2026.
In Aug, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 13.209% volatility is expected.
Pessimistic target level: 82.50
Optimistic target level: 95.06
Target values for the price of one Biogen share for Oct 2026.
In Oct, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 12.365% volatility is expected.
Pessimistic target level: 90.09
Optimistic target level: 102.80
Target values for the price of one Biogen share for Oct 2026.
In Oct, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 13.780% volatility is expected.
Pessimistic target level: 94.82
Optimistic target level: 109.97
Target values for the price of one Biogen share for Dec 2026.
In Dec, the Negative dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 9.437% volatility is expected.
Pessimistic target level: 94.01
Optimistic target level: 103.80
Target values for the price of one Biogen share for Dec 2026.
In Dec, the Positive dynamics for Biogen Inc. shares will prevail with possible monthly volatility of 8.585% volatility is expected.
Pessimistic target level: 98.23
Optimistic target level: 107.45
